Endotoxaemia in haemodialysis: a novel factor in erythropoetin resistance? - Wikidata - awgldk - TriplyDB

Endotoxaemia in haemodialysis: a novel factor in erythropoetin resistance?

Endotoxaemia in haemodialysis: a novel factor in erythropoetin resistance?

http://www.wikidata.org/entity/Q34328779

about

Circulating bacterial-derived DNA fragment level is a strong predictor of cardiovascular disease in peritoneal dialysis patients Remote ischaemic conditioning-therapeutic opportunities in renal medicine.Intestinal Barrier Disturbances in Haemodialysis Patients: Mechanisms, Consequences, and Therapeutic Options.Effects of weight-based ultrafiltration rate limits on intradialytic hypotension in hemodialysis.Circulating Bacterial Fragments as Cardiovascular Risk Factors in CKD.

P2860

Q35641502-3E63DF3D-3E5A-479B-8DB9-18249F996E53 Q38159918-FB238471-F231-48B5-BD36-786EEBE4457F Q38757951-84AE41AD-DB71-4843-AC2B-E80869A0D819 Q47204294-57A8A3AE-2F86-4650-A9FD-95055ACF4A37 Q54233821-0ECD9A73-7B4A-4D0D-AD1B-6F3F7C0BC2A9

P2860

Endotoxaemia in haemodialysis: a novel factor in erythropoetin resistance?

http://www.wikidata.org/entity/Q34328779

description

2012 nî lūn-bûn

@nan

2012 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Endotoxaemia in haemodialysis: a novel factor in erythropoetin resistance?

@ast

Endotoxaemia in haemodialysis: a novel factor in erythropoetin resistance?

@en

Endotoxaemia in haemodialysis: a novel factor in erythropoetin resistance?

@nl

type

label

Endotoxaemia in haemodialysis: a novel factor in erythropoetin resistance?

@ast

Endotoxaemia in haemodialysis: a novel factor in erythropoetin resistance?

@en

Endotoxaemia in haemodialysis: a novel factor in erythropoetin resistance?

@nl

prefLabel

Endotoxaemia in haemodialysis: a novel factor in erythropoetin resistance?

@ast

Endotoxaemia in haemodialysis: a novel factor in erythropoetin resistance?

@en

Endotoxaemia in haemodialysis: a novel factor in erythropoetin resistance?

@nl

P1433

Q34328779-5B0F7155-FB37-4121-8C13-A8A47936C515

P1476

Q34328779-B177E780-51F9-400B-B584-7E7353E5F3B1

P2093

Q34328779-332B5CE9-89B9-466A-80EA-0BF2BCF70055

Q34328779-9A3F155F-E9F5-4315-8089-648E700CB84D

Q34328779-DA316285-62A2-4C33-8838-7553943E118F

P2860

Q34328779-055A8EFB-8B0B-4DE3-B40A-203953C1E064

Q34328779-1012FA17-E547-4BE6-BA8A-367A6212AEC5

Q34328779-2DD6FFAD-AFCD-4171-AFD3-195FF5A013BF

Q34328779-2EDF2E97-C51A-44B2-893A-5747CD8F6699

Q34328779-30EDC856-7BEE-436D-8726-E84CE79D4A50

Q34328779-3CE3ED09-8EEA-42A0-8626-E075CA415A39

Q34328779-442A134B-4A6B-4BA4-9FFB-73D38B133350

Q34328779-5060E292-3177-4197-9158-D0908C18FC94

Q34328779-59766FDC-D6D2-4C7F-AF01-18421A3F1D3C

Q34328779-5EA7B467-A705-4D03-94BA-E75D72ACAB27

P304

Q34328779-E337B235-3B14-45B4-8456-01158890A2A5

P31

Q34328779-BD408D17-DFF9-4878-BFEB-BE9C73156978

P356

Q34328779-C24D8715-709D-495C-9AAD-C7921F1BE41B

P407

Q34328779-4CD487BA-4FE4-43D4-B54C-C3A3B52DB04F

P433

Q34328779-F5729C09-C99B-4086-9EEE-057CF30B8428

P478

Q34328779-E616AEA2-0220-4166-AB03-C005CD44BC96

P50

Q34328779-C80E43A3-D886-4166-B2ED-7A8123708F24

Q34328779-D3EC1693-4206-4C60-A40E-C32E02E80A65

P577

Q34328779-BC82906B-45C3-4B85-A78E-6D8AA383B4D3

P5875

Q34328779-C7BD3469-0E30-42D5-872F-B4DC31CEECBC

P698

Q34328779-E5146955-F24D-442D-9E82-9D3779E2041D

P932

Q34328779-C90BB3FA-094B-4EA1-B040-3230AA8E48BB

P356

JOURNAL.PONE.0040209

P1433

P1476

Endotoxaemia in haemodialysis: a novel factor in erythropoetin resistance?

@en

P2093

Christopher W McIntyre

http://www.w3.org/2001/XMLSchema#string

Laura E A Harrison

http://www.w3.org/2001/XMLSchema#string

Philip K T Li

http://www.w3.org/2001/XMLSchema#string

P2860

Microbial translocation is a cause of systemic immune activation in chronic HIV infection

Normalization of hemoglobin level in patients with chronic kidney disease and anemia

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

Relative risk of death in UK haemodialysis patients in relation to achieved haemoglobin from 1999 to 2005: an observational study using UK Renal Registry data incorporating 30,040 patient-years of follow-up.

Regression of left ventricular hypertrophy after conversion to nocturnal hemodialysis.

Hyporesponsiveness to recombinant human erythropoietin.

Anemia of chronic disease.

The importance of the gastrointestinal system in the pathogenesis of heart failure.

Circulating endotoxemia: a novel factor in systemic inflammation and cardiovascular disease in chronic kidney disease

Clinical factors influencing sensitivity and response to epoetin.

P304

e40209

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0040209

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

James O. Burton

Cheuk-Chun Szeto

P577

2012-06-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

228331849

http://www.w3.org/2001/XMLSchema#string

P698

22768256

http://www.w3.org/2001/XMLSchema#string

P932

3387022

http://www.w3.org/2001/XMLSchema#string